Dr. Bhanushali Sonali Suresh Tara
16 May 2024 - 2 min read
Nedosiran for Primary Hyperoxaluria Type 1 - An Overview
Nedosiran is an RNA-targeted therapy to reduce oxalate production by inhibiting hepatic lactate dehydrogenase, thus treating primary hyperoxaluria Type 1.
29 Feb 2024 . 8 min read
Comprehensive Medical Second Opinion.
Chat with a Doctor
Starting @ just $59